European Legislation for Clinical Research – Implementation in Belgium
Book a session
| Date | Product | Location | Price | |
|---|---|---|---|---|
| No sessions are planned at this time, however if you are interested in taking this course click here | ||||
| If you would like to have this course as an in-house session click here | ||||
About this course
Reasons to attend
This Clinical Research Legislation course is co-developed and given by the Belgian Competent Authorities. European legislation is one thing; the practical implementation in Belgian is something else. The programme has been revised to include the most recent developments related to the implementation of the EU Clinical Trial Regulation 536/2014.What's included?
- Documents and materials related to this course are included
- Globally recognised certificates awarded after test completion
- This course has been granted PharmaTrain Recognition
Course schedule
- One Day face-to-face training: 09h00-17h00
Course Description
This course has been revised to capture the most recent developments and focuses on the current and future legal requirements of performing clinical trials with medicinal products in Belgium.The Belgian law of 7 May 2004 on experiments on humans implements the European directive 2001/20/EC is currently valid. A number of Royal Decrees and circular letters have also been published, which detail the practical implementation of the law. This training helps participants understand how the present Belgian legal rules should be applied.A separate part of the training is dedicated to the European Clinical Trial Regulation 536/2014, which will become applicable in 2016 and which will repeal directive 2001/20/EC after a transition phase. Information relating to steps under development for implementation in Belgium will be presented.Programme highlight
- Overview of current European and Belgian Legislation concerning Clinical Trials (incl. Amendments & Safety Reporting)
- Clinical Trials and the Belgian Ethics Committees
- The European Clinical Trial Regulation 536/2014 in short
- Update on the implementation of the EU Clinical Trial Regulation 536/2014
- Current Clinical Trial Requirements by the Belgian Competent Authority
Learning objectives
- Provide an overview of the implementation of the EU directive into Belgian law
- Detail the practical implementation, illustrated with examples
- Understand all Belgian laws related to Clinical Research
- Get an update on the latest status on the implementation of the EU Clinical Trial Regulation 536
Who should attend
Everyone involved in clinical research, including: Pharmaceutical companies, Contract Research Organisations (CROs), Investigators, Site Personnel and Ethics Committee Members. People from clinical operations, regulatory affairs, quality assurance and pharmacovigilance departments within the pharmaceutical industry
Competencies
This course covers competencies that are part of the ECCRT Competency Framework
- Scientific Concepts Research Design (0)
- Ethical & Participants Safety Considerations (0)
- Investigational Product Development and Regulation (2)
- Clinical Studies Operations (GCPs or ISO 14155) (2)
- Study and Site Management (0)
- Data Management and Informatics (0)
- Leadership and Professionalism (0)
- Communication (0)
- Teamwork (0)
- Business acumen (0)
Trainers
Gerda Sabbe
Medical Device Works
I would like to thank the trainers of ECCRT with the course: “EU Clinical Trial Directive: implementation in Belgium”. Even though my current interest is mostly in “medical devices”, I learned a great deal from both Mr. Bonnarens and Dr. Verbeeck. The information was presented very well, even though the materials can, in itself, be quite boring. In addition the practical handling of the subscription, reception, training, breaks and conclusion of the meeting went smoothly: congratulations.